BioSpace News Archive

In recognition of their contributions to sustainable business practices, two leaders from MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, were selected as recipients in the Business Intelligence Group 2023 Sustainability Awards program.

Paratek Pharmaceuticals, Inc. announced, based on a preliminary vote count, that stockholders have approved the merger agreement proposal at Paratek’s special meeting of stockholders, in connection with the previously announced definitive agreement to be acquired by Gurnet Point Capital and Novo Holdings A/S.

Ms. Zhao Yan, president and general manager of Bloomage Biotech, shared her insights on how emerging biotechnologies can contribute to the achievement of sustainable development goals (SDG) at the Innovation for Industrial Sustainability event held in New York on Sept. 17.

Unravel Biosciences, Inc., (“Unravel”), a therapeutics company leveraging a machine-learning model of human health to advance drugs for complex diseases, today announced the release of a groundbreaking new initiative, rareSHIFT™, to facilitate patient-centric drug discovery and translation with unprecedented speed.

B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for AQUAbase nX Reverse Osmosis System.

Hospitalized adult patients whose medical conditions worsen after being admitted, requiring escalation of care, such as transfer to the intensive care unit (ICU) or intervention of a rapid response team, may benefit from monitoring by artificial intelligence (AI).

One in eight women will be diagnosed with breast cancer during their lifetime.

Allos Pharma Inc., a biopharmaceutical company specializing in the development of treatments for rare neurological disorders, announced that it has expanded its intellectual property rights with a new patent family.

AB Science SA (Euronext – FR0010557264 – AB) today provided an update on the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) timetable for examination of the masitinib marketing authorization application in amyotrophic lateral sclerosis (ALS).

Tenovi, the leading provider of comprehensive remote patient monitoring devices and software solutions, announced today the appointment of Jay Lenick as the company’s Chief Revenue Officer (CRO), marking a significant milestone in the company’s ongoing expansion.